Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two‐year period using continuous bronchoscopy: A case report

Programmed cell death‐1 immune checkpoint inhibitor (ICI) antibody has proven to be effective in advanced non‐small cell lung cancer (NSCLC) patients positive for programmed cell death‐1 ligand‐1. However, there are currently no reports which evaluate drug efficacy by continuous bronchoscopic observ...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Kei, Kida, Hirotaka, Handa, Hiroshi, Inoue, Takeo, Miyazawa, Teruomi, Mineshita, Masamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180542/
https://www.ncbi.nlm.nih.gov/pubmed/32142590
http://dx.doi.org/10.1111/1759-7714.13390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180542/
https://www.ncbi.nlm.nih.gov/pubmed/32142590
http://dx.doi.org/10.1111/1759-7714.13390

Ejemplares similares